Not applicableStudy completedNCT01365962What this trial is testingBiomarker in Tumor Tissue Samples From Patients With RhabdomyosarcomaWho this might be right forSarcoma Children's Oncology Group 60
Large-scale testing (Phase 3)Study completedNCT00430118What this trial is testingCombination Chemotherapy Based on Risk of Relapse in Treating Young Patients With Acute Lymphoblastic LeukemiaWho this might be right forLeukemia University Hospital Schleswig-Holstein 4,559
Early research (Phase 1)Study completedNCT00049023What this trial is testingRadiolabeled Octreotide in Treating Children With Advanced or Refractory Solid TumorsWho this might be right forBrain and Central Nervous System TumorsGastrointestinal Carcinoid TumorIslet Cell Tumor+4 more O'Dorisio, M S 27
Testing effectiveness (Phase 2)Study completedNCT00526292What this trial is testingChemotherapy and a Donor Natural Killer Cell Infusion in Treating Patients With Relapsed or Persistent Leukemia or Myelodysplastic Syndrome After a Donor Stem Cell TransplantWho this might be right forLeukemiaMyelodysplastic Syndromes Memorial Sloan Kettering Cancer Center 12
Early research (Phase 1)Ended earlyNCT00087009What this trial is testingBeta-Glucan and Rituximab in Treating Young Patients With Relapsed or Progressive Lymphoma or Leukemia, or Lymphoproliferative Disorder Related to Donor Stem Cell TransplantationWho this might be right forLeukemiaLymphomaLymphoproliferative Disorder Memorial Sloan Kettering Cancer Center 3
Testing effectiveness (Phase 2)Looking for participantsNCT03938987What this trial is testingAnti-CD19, Dual Co-stimulatory (4-1BB, CD3ζ) Chimeric Antigen Receptor T-cells in Patients With Relapsed/Refractory Aggressive Lymphoma or Acute Lymphoblastic Leukemia (ALL)Who this might be right forRelapsed Non Hodgkin LymphomaRelapsed Adult ALLRelapsed Pediatric ALL University of Alberta 63
Testing effectiveness (Phase 2)UnknownNCT00008164What this trial is testingUmbilical Cord Blood and Placental Blood Transplantation in Treating Patients With Hematologic Cancer or Aplastic AnemiaWho this might be right forChildhood Langerhans Cell HistiocytosisLeukemiaLymphoma+3 more Herbert Irving Comprehensive Cancer Center 30
Early research (Phase 1)Study completedNCT01319864What this trial is testingPOETIC Plerixafor as a Chemosensitizing Agent for Relapsed Acute Leukemia and MDS in Pediatric PatientsWho this might be right forRelapsed/Refractory AMLRelapsed/Refractory ALLSecondary AML/MDS+3 more Seattle Children's Hospital 20
Testing effectiveness (Phase 2)Active Not RecruitingNCT04320888What this trial is testingSelpercatinib for the Treatment of Advanced Solid Tumors, Lymphomas, or Histiocytic Disorders With Activating RET Gene Alterations, a Pediatric MATCH Treatment TrialWho this might be right forHematopoietic and Lymphatic System NeoplasmRecurrent EpendymomaRecurrent Ewing Sarcoma+35 more National Cancer Institute (NCI) 1
Testing effectiveness (Phase 2)Ended earlyNCT00450983What this trial is testingDonor Peripheral Stem Cell Transplant and Donor Natural Killer Cell Transplant After Total-Body Irradiation, Thiotepa, Fludarabine, and Muromonab-CD3 in Treating Patients With Leukemia or Other Blood DiseasesWho this might be right forGraft Versus Host DiseaseLeukemiaMyelodysplastic Syndromes Fred Hutchinson Cancer Center 1
Testing effectiveness (Phase 2)Study completedNCT00006462What this trial is testingGemcitabine in Treating Children With Relapsed or Refractory Acute Lymphoblastic Leukemia or Acute Myelogenous LeukemiaWho this might be right forLeukemia Children's Oncology Group 32
Not applicableStudy completedNCT01419496What this trial is testingStudy of Proteins in Promoting Chemotherapy Resistance in Samples From Patients With Acute Myeloid LeukemiaWho this might be right forLeukemia Children's Oncology Group 40
Early research (Phase 1)Looking for participantsNCT07297979What this trial is testingEvaluation of Xaluritamig in Adults, Adolescents and Children With Relapsed or Refractory Ewing Sarcoma (EWS)Who this might be right forEwing Sarcoma Amgen 50
Not applicableStudy completedNCT00856388What this trial is testingFludarabine Phosphate, Melphalan, Total-Body Irradiation, Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer or Bone Marrow Failure DisordersWho this might be right forAccelerated Phase Chronic Myelogenous LeukemiaAcute Myeloid Leukemia With Multilineage Dysplasia Following Myelodysplastic SyndromeAdult Acute Lymphoblastic Leukemia in Remission+97 more Roswell Park Cancer Institute 62
Early research (Phase 1)Study completedNCT01049841What this trial is testingPerifosine With Temsirolimus for Recurrent Pediatric Solid TumorsWho this might be right forPediatric Solid Tumors Memorial Sloan Kettering Cancer Center 23
Testing effectiveness (Phase 2)Study completedNCT00346359What this trial is testingFludarabine and Busulfan Followed by Donor Peripheral Stem Cell Transplant and Antithymocyte Globulin, Tacrolimus, and Methotrexate in Treating Patients With Myeloid CancerWho this might be right forChronic Myeloproliferative DisordersGraft Versus Host DiseaseLeukemia+2 more Fred Hutchinson Cancer Center 40
Testing effectiveness (Phase 2)Study completedNCT00679354What this trial is testingCilengitide in Treating Younger Patients With Recurrent or Progressive High-Grade Glioma That Has Not Responded to Standard TherapyWho this might be right forChildhood High-grade Cerebellar AstrocytomaChildhood High-grade Cerebral AstrocytomaRecurrent Childhood Anaplastic Astrocytoma+7 more National Cancer Institute (NCI) 30
Testing effectiveness (Phase 2)Study completedNCT01471782What this trial is testingClinical Study With Blinatumomab in Pediatric and Adolescent Patients With Relapsed/Refractory B-precursor Acute Lymphoblastic LeukemiaWho this might be right forAcute Lymphoblastic Leukemia Amgen Research (Munich) GmbH 93
Early research (Phase 1)WithdrawnNCT01861990What this trial is testingValproic Acid in Childhood Progressive Brain TumorsWho this might be right forPediatric Brain TumorGliomaAnaplastic Astrocytoma+2 more Medical University of South Carolina
Testing effectiveness (Phase 2)Study completedNCT00118326What this trial is testingDonor Bone Marrow Transplant in Treating Young Patients With Cancer or a Non-Cancerous DiseaseWho this might be right forKidney CancerLeukemiaLymphoma+3 more Fred Hutchinson Cancer Center